3,4-dihydroxyphenylacetic acid has been researched along with Hyperprolactinaemia in 8 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of this study was to determine the effects of acute hypoprolactinemia on tuberoinfundibular dopamine (DA) neurons using a rabbit anti-rat prolactin antiserum (PRL-AB) to immunoneutralize circulating prolactin under basal conditions and at various times after haloperidol-induced hyperprolactinemia." | 3.70 | Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies. ( Fleckenstein, AE; Hentschel, K; Lawson, DM; Lookingland, KJ; Moore, KE; Toney, TW, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Laurentiis, A | 1 |
Pisera, D | 1 |
Caruso, C | 1 |
Candolfi, M | 1 |
Mohn, C | 1 |
Rettori, V | 1 |
Seilicovich, A | 1 |
Hernández, ML | 1 |
Fernández-Ruiz, JJ | 1 |
Navarro, M | 1 |
de Miguel, R | 1 |
Cebeira, M | 1 |
Vaticón, L | 1 |
Ramos, JA | 1 |
Yang, JY | 1 |
Pan, JT | 1 |
Hentschel, K | 1 |
Fleckenstein, AE | 1 |
Toney, TW | 1 |
Lawson, DM | 1 |
Moore, KE | 1 |
Lookingland, KJ | 1 |
MohanKumar, PS | 1 |
MohanKumar, SM | 1 |
Quadri, SK | 1 |
Voogt, JL | 1 |
Paradisi, R | 1 |
Grossi, G | 1 |
Pintore, A | 1 |
Venturoli, S | 1 |
Porcu, E | 1 |
Capelli, M | 1 |
Flamigni, C | 1 |
Mechanick, JI | 1 |
Cohen-Becker, IR | 1 |
Gregerson, KA | 1 |
Selmanoff, M | 1 |
Benfenati, F | 1 |
Ferretti, C | 1 |
Cimino, M | 1 |
Vantini, G | 1 |
Lipartiti, M | 1 |
Muccioli, G | 1 |
Di Carlo, R | 1 |
Algeri, S | 1 |
8 other studies available for 3,4-dihydroxyphenylacetic acid and Hyperprolactinaemia
Article | Year |
---|---|
Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bacterial Infections; Dopamine; Epinephrine; Hyperprolactin | 2002 |
Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Hyperprolactinemia; Inje | 1994 |
Enhanced tuberoinfundibular dopaminergic neuron activity in thyroidectomized, ovariectomized and estrogen-treated rats with hyperprolactinemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Cysteamine; Dopamine; Estrogens; Female; Hyp | 1994 |
Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Dopamine; Dopamine Antagon | 2000 |
Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Dopa | 2001 |
Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Brain; Carbidopa; Chromatography, High Pressure Liquid; Disul | 1991 |
Distribution of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylglycol (DOPEG) in microdissected brain structures and the pituitary gland: metabolite changes in the median eminence in response to hyperprolactinemia and suckling.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Suckling; Brain; Dissection; Glycols; Hyperprolact | 1987 |
Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Domperidone; Dopamine; Drug Administration | 1986 |